Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2017 August;58(4) > The Journal of Cardiovascular Surgery 2017 August;58(4):508-17

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  RECENT DEVELOPMENTS IN THE MANAGEMENT OF IN-STENT RESTENOSIS 

The Journal of Cardiovascular Surgery 2017 August;58(4):508-17

DOI: 10.23736/S0021-9509.17.09953-0

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

In-stent restenosis management: the best is yet to come

Jos C., van den BERG 1, 2

1 Universitätsinstitut für Diagnostische, Interventionelle und Pädiatrische Radiologie, Inselspital, Bern, Switzerland; 2 Centro Vascolare Ticino, Ospedale Regionale di Lugano, Lugano, Switzerland


PDF


The use of drug-eluting stents and of drug-coated balloons have mitigated the prevalence of in-stent restenosis, however in-stent remains a problem that continues to affect the long-term outcomes of femoro-popliteal endovascular therapy. This paper will provide an overview on the latest data with regard to the treatment of femoro-popliteal in-stent restenosis.


KEY WORDS: Femoral artery - Vascular graft occlusion - Drug-eluting stents - Balloon angioplasty

top of page